From: Qualifying and quantifying the precision medicine rhetoric
Theme | Category | Number of PM-like efforts | Percentage of total |
---|---|---|---|
Location of funding institution | Domestic | 36 | 33.3% |
Global | 72 | 66.7% | |
Longitudinal | 22 | 20.2% | |
Sample size | ≥ 10,000 | 19 | 17.6% |
< 10,000 | 16 | 14.8% | |
Unknown | 70 | 67.6% | |
Data types | Unidimensional | 46 | 42.6% |
Two or more | 58 | 53.7% | |
Unclear | 4 | 3.7% | |
Biospecimen | 91 | 84.3% | |
Biospecimen only | 35 | 32.4% | |
EHR | 45 | 41.7% | |
PPI | 26 | 24.0% | |
Sensor | 11 | 10.2% | |
Duration | Explicit | 17 | 15.7% |
Participant as partners | Yes | 25 | 23.1% |
No | 25 | 23.1% | |
Unknown | 58 | 53.7% | |
Study Aim | Database | 69 | 63.9% |
Clinical Trial | 44 | 40.7% | |
Funding | Government | 59 | 54.6% |
Industry | 35 | 32.4% | |
Nonprofit | 12 | 11.1% | |
Donations | 7 | 6.5% |